Mirus Bio receives ISO 13485:2016 certification, underscoring the quality of processes used to support GMP product portfolio. Read more

Search
Close this search box.

On Demand Webinar

Optimize Your Bioprocess and Save Millions

Lower your cost-per-dose by using reagents and enhancers that scale up your AAV asset while scaling down your upstream and downstream costs

See How

30 min

What You'll Learn:

Next-Generation AAV Platforms

What strategies and technologies can offer you a manufacturing boost. How can these upgrades boost your technical and operational efficiency immediately.

Challenges in Bioprocess Economics

The current and upcoming challenges beyond Phase 3 in viral vector manufacturing and how they affect different stages of your gene therapy pipeline.

Transfection Reagent Comparison

The outcomes of a real-world case study comparing top transfection reagents, and how each effects your drug asset’s economic and operational efficiency.

Run Your Own Analysis

Compare transfection reagents and cut your cost per dose in half. See how much your lab can save when scaling your viral production with the transfection calculator.

Labs and manufacturers save via:

  • Fewer bioreactor runs
  • Less pDNA required
  • Longer complex formulation windows
  • 8 other variables
Calculate Savings

THE EXPERT

Fletcher Malcom

Strategy, Product and Business Development
Mirus Bio

Fletcher Malcom is the Strategy, Product, and Business Development Director at Mirus Bio, a company committed to equipping biopharmaceutical innovators with next generation transfection solutions for all cell culture applications.

Fletcher has 20 years of biopharmaceutical experience, with expertise spanning enhancing operational efficiencies in the industry. His combined bench and business knowledge helps drive growth in all of the systems that he touches.

Fletcher graduated from Hamilton College and Babson College and has scaled multiple products to GMP production scale at Mirus Bio, Nanopareil, and Repligen Corporation.

Start scaling your upstream efforts today

Or schedule a meeting with a transfection expert

Watch Now

Start scaling your upstream efforts today

Or schedule a meeting with a transfection expert

Watch Now 
On Demand Webinar

Optimize Your Bioprocess  and Save Millions

Lower your cost-per-dose by using reagents and enhancers that scale up your AAV asset while scaling down your upstream and downstream costs

See How

What you’ll find inside:

  • How upstream processes achieve 2-10X higher titers and percent full capsids with TransIT-VirusGEN® and RevIT™ AAV Enhancer
  • What transfection efficiency results you can expect across multiple serotypes, media, and suspension cell types
  • How to scale from R&D to GMP
  • How smart manufacturing processes enable affordability to drug developers and greater access to therapeutics for patients
  • How upstream can handoff to downstream with higher quality
  • How to cut costs on plasmid DNA
  • How to compare transfection reagents
Previous slide
Next slide